Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis
Neonc Technologies, Inc.
Neonc Technologies, Inc.
H. Lee Moffitt Cancer Center and Research Institute
M.D. Anderson Cancer Center
7 Hills Pharma, LLC
Vyriad, Inc.
TCR2 Therapeutics
Incyte Corporation
Vanderbilt-Ingram Cancer Center
Bristol-Myers Squibb
Gritstone bio, Inc.
H. Lee Moffitt Cancer Center and Research Institute
Merck Sharp & Dohme LLC
Incyte Corporation
Incyte Corporation
NYU Langone Health